Business Description
Shattuck Labs Inc
NAICS : 541714
SIC : 2834
ISIN : US82024L1035
Share Class Description:
STTK: Ordinary SharesDescription
Shattuck Labs Inc is a clinical-stage biotechnology company pioneering the development of dual-sided fusion proteins as an entirely new class of biologic medicine. Its product candidate, SL-172154, has been rationally designed to simultaneously inhibit the CD47/SIRPa checkpoint interaction to restore an anti-tumor immune response and to activate the CD40 costimulatory receptor to bolster an immune response. Its product candidate, SL-279252, which is being developed in collaboration with Takeda Pharmaceuticals, or Takeda, has been rationally designed to simultaneously inhibit the PD-1/PD-L1 interaction and activate the OX40 receptor.
Financial Strength
5/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| Cash-To-Debt | 24.91 | |||||
| Equity-to-Asset | 0.86 | |||||
| Debt-to-Equity | 0.04 | |||||
| Debt-to-EBITDA | -0.05 | |||||
| Interest Coverage | N/A |
N/A
|
N/A
| |||
| Piotroski F-Score | 3/9 | |||||
| Altman Z-Score | -3.66 | |||||
| Beneish M-Score | 0.5 | |||||
| WACC vs ROIC | ||||||
Growth Rank
1/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| 3-Year Revenue Growth Rate | -60.7 | |||||
| 3-Year EBITDA Growth Rate | 4.1 | |||||
| 3-Year EPS without NRI Growth Rate | 4.6 | |||||
| 3-Year FCF Growth Rate | 4.8 | |||||
| 3-Year Book Growth Rate | -25.5 | |||||
| Future 3-5Y EPS without NRI Growth Rate | 23.56 |
Momentum Rank
2/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| 5-Day RSI | 45.94 | |||||
| 9-Day RSI | 45.61 | |||||
| 14-Day RSI | 44.5 | |||||
| 6-1 Month Momentum % | -74.59 | |||||
| 12-1 Month Momentum % | -84.77 |
Liquidity Ratio
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| Current Ratio | 7.96 | |||||
| Quick Ratio | 7.96 | |||||
| Cash Ratio | 7.26 |
Dividend & Buy Back
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| 3-Year Average Share Buyback Ratio | -4.2 | |||||
| Shareholder Yield % | 1.05 |
Profitability Rank
1/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| Operating Margin % | -1241.29 | |||||
| Net Margin % | -1156.46 | |||||
| FCF Margin % | -972.51 | |||||
| ROE % | -62.69 | |||||
| ROA % | -54.99 | |||||
| ROIC % | -371.25 | |||||
| ROC (Joel Greenblatt) % | -578.61 | |||||
| ROCE % | -65.54 |
GF Value Rank
2/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| PS Ratio | 8.54 | |||||
| PB Ratio | 0.55 | |||||
| Price-to-Tangible-Book | 0.55 | |||||
| EV-to-EBIT | 0.42 | |||||
| EV-to-Forward-EBIT | -0.58 | |||||
| EV-to-EBITDA | 0.45 | |||||
| EV-to-Forward-EBITDA | -0.58 | |||||
| EV-to-Revenue | -5.27 | |||||
| EV-to-Forward-Revenue | 12.18 | |||||
| EV-to-FCF | 0.54 | |||||
| Price-to-Net-Current-Asset-Value | 0.63 | |||||
| Price-to-Net-Cash | 0.71 | |||||
| Earnings Yield (Greenblatt) % | 238.1 | |||||
| FCF Yield % | -118.09 |
Historical Operating Revenue by Business Segment
Historical Operating Revenue by Geographic Region
Guru Trades
See DetailsInsider Trades
See DetailsGurus Latest Trades with NAS:STTK
You need a Premium membership or above to view this section.
Take a 7-Day Free Trial
No Available Data
Peter Lynch Chart
Performance
Dividend
Log
Bar
Annualized Return % Â
Total Annual Return % Â
Shattuck Labs Inc Executives
DetailsAnalyst Estimate
Key Statistics
| Name | Value | ||
|---|---|---|---|
| Revenue (TTM) (Mil $) | 6.435 | ||
| EPS (TTM) ($) | -1.53 | ||
| Beta | 1.54 | ||
| Volatility % | 289.34 | ||
| 14-Day RSI | 44.5 | ||
| 14-Day ATR ($) | 0.121284 | ||
| 20-Day SMA ($) | 1.162 | ||
| 12-1 Month Momentum % | -84.77 | ||
| 52-Week Range ($) | 0.94 - 11.76 | ||
| Shares Outstanding (Mil) | 47.74 |
Piotroski F-Score Details
Year:
| Component | Result | ||
|---|---|---|---|
| Piotroski F-Score | 3 | ||
| Positive ROA | |||
| Positive CFROA | |||
| Higher ROA yoy | |||
| CFROA > ROA | |||
| Lower Leverage yoy | |||
| Higher Current Ratio yoy | |||
| Less Shares Outstanding yoy | |||
| Higher Gross Margin yoy | |||
| Higher Asset Turnover yoy |
Shattuck Labs Inc Filings
| Filing Date | Document Date | Form | ||
|---|---|---|---|---|
| No Filing Data | ||||
Shattuck Labs Inc Stock Events
| Event | Date | Price($) | ||
|---|---|---|---|---|
| No Event Data | ||||
Shattuck Labs Inc Frequently Asked Questions
What is Shattuck Labs Inc(STTK)'s stock price today?
The current price of STTK is $1.11. The 52 week high of STTK is $11.76 and 52 week low is $0.94.
When is next earnings date of Shattuck Labs Inc(STTK)?
The next earnings date of Shattuck Labs Inc(STTK) is 2025-02-28 Est..
Does Shattuck Labs Inc(STTK) pay dividends? If so, how much?
Shattuck Labs Inc(STTK) does not pay dividend.
Press Release
| Subject | Date | |||
|---|---|---|---|---|
| No Press Release | ||||
Survey
We'd love to learn more about your experiences on GuruFocus.com and how we can improve!
Take Survey
Follow Us
Disclaimers